What is the most common lung cancer in the US?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Non-Small Cell Lung Cancer (NSCLC) is the Most Common Lung Cancer in the United States

Non-small cell lung cancer (NSCLC) accounts for more than 80-85% of all lung cancer cases in the United States, making it by far the most common type. 1, 2

Breakdown of Lung Cancer Types

NSCLC Predominance

  • NSCLC represents 85-90% of all lung cancers according to the American Society of Clinical Oncology 2
  • Multiple NCCN guidelines consistently report NSCLC accounts for >80-85% of cases 1
  • This leaves small cell lung cancer (SCLC) representing fewer than 20% of cases 1

NSCLC Subtypes

Within NSCLC, there are two major histologic categories 1:

Nonsquamous carcinomas:

  • Adenocarcinoma is the single most common histologic subtype of lung cancer in the United States 1
  • Adenocarcinoma accounts for approximately 40% of all lung cancers 1
  • It is the most frequently occurring cell type in nonsmokers 1

Squamous cell (epidermoid) carcinoma:

  • Represents approximately 30% of lung cancers 1
  • Has the strongest association with tobacco smoking exposure 2, 3

Other subtypes:

  • Large-cell carcinoma accounts for 5-10% 1
  • Other rare subtypes comprise the remainder 1

Clinical Context

  • Smoking is responsible for approximately 80% of all lung cancer cases 2, 3
  • Despite NSCLC being more common, lung cancer remains the leading cause of cancer death in the United States, with an estimated 125,070 deaths in 2024 1
  • The overall 5-year survival rate for lung cancer patients is approximately 25.4%, with adenocarcinoma having a 32.2% 5-year survival rate 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis of Lung Malignancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Squamous Cell Carcinoma of the Lung

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.